Oracle (ORCL) confirms pricing of USD 10 bln senior notes with maturities from 2029-2046 and prices USD 10bln stock offering at USD 116/shr

Oracle (ORCL) confirms pricing of USD 10 bln senior notes with maturities from 2029-2046 and prices USD 10bln stock offering at USD 116/shr.

A paired jumbo debt and equity raise of this size is the established template for mega-cap issuers funding a heavy capex programme while defending credit metrics: the bond leg locks in term funding across the curve, and the equity leg signals to the rating agencies that leverage will not be left to absorb the spend alone. The 2029 to 2046 maturity spread is the standard multi-tranche structure for deals of this scale, built to tap demand at the belly and the long end simultaneously. Large technology issuers have historically found deep sponsorship for such offerings, with the equity tranche typically priced at a discount to the prior close and the shares tending to trade around the offer level in the immediate aftermath. What separates a well-received raise from a dilutive overhang is the stated use of proceeds and the agency response: earmarked capex with supportive rating commentary has tended to be absorbed cleanly, while raises framed as general corporate purposes have drawn more scepticism about the return profile. Worth noting is the size of the order books, the new issue concessions versus the existing curve, and any concurrent guidance on the pace of the underlying investment programme. Oracle has prior form as a large and frequent issuer, so execution mechanics here are familiar territory for the credit desks.